Cardio Diagnostics Holdings is trading 12.87% up at $1.93 as of August 11, 2026, with healthcare-sector momentum the strongest available explanation.
- No new company-specific announcement was identified to explain the move.
- Healthcare stocks gained after Bristol Myers Squibb announced a roughly $2.3 billion Houston manufacturing investment, part of its larger U.S. commitment, Reuters reported.
- Gains across healthcare indexes and ETFs further supported a sector-driven interpretation.